These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20857)

  • 1. Interaction of drugs with apomorphine, tryptamine and norepinephrine. A new 'in vivo' approach: the ATN-test in rats.
    Niemegeers CJ; Lenaerts FM; Artois KS; Janssen PA
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):238-53. PubMed ID: 20857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium inhibition of norepinephrine and dopamine receptors.
    Flemenbaum A
    Biol Psychiatry; 1977 Aug; 12(4):563-72. PubMed ID: 560884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effects of local injections of dopamine and analogs into the neostriatum and nucleus accumbens.
    Andén NE
    Adv Biochem Psychopharmacol; 1977; 16():385-9. PubMed ID: 196491
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antagonism between L-DOPA and apomorphine in their effects on rat behavior].
    Allikmets LKh; Zharkovskiĭ Am; Vasar EE
    Biull Eksp Biol Med; 1977 Jul; 84(7):51-3. PubMed ID: 560890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature of receptors involved in apomorphine responses in pigeons.
    Saxena PN; Chawla N; Johri MB; Iqbal S
    Psychopharmacology (Berl); 1977 Jun; 53(1):89-95. PubMed ID: 407618
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of transmitter mechanisms in the behavioural effects of angiotensin II.
    Georgiev V
    Pol J Pharmacol Pharm; 1990; 42(6):553-62. PubMed ID: 1983291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine hypothermia: interaction with serotonergic agents.
    Kulkarni SK
    Pol J Pharmacol Pharm; 1980; 32(1):15-20. PubMed ID: 7192860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 11. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitter control of thyrotrophin secretion in hypothyroid rats.
    Männistö PT; Ranta T
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):100-7. PubMed ID: 29423
    [No Abstract]   [Full Text] [Related]  

  • 13. Central effects following repeated treatment with antidepressant drugs.
    Maj J
    Pol J Pharmacol Pharm; 1984; 36(2-3):87-99. PubMed ID: 6089162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of antiserotonergic agents on the action of dopaminergic drugs.
    Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
    Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats with normosensitive DA receptors.
    Arnt J; Hyttel J
    Pharmacopsychiatry; 1988 Jan; 21(1):24-7. PubMed ID: 2966410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of alpha-adrenergic receptor stimulant drugs on amphetamine or apomorphine-induced stereotypy in rats.
    Zebrowska-Lupina I; Kleinrok Z; Kozyrska C; Wielosz M
    Pol J Pharmacol Pharm; 1978; 30(4):459-67. PubMed ID: 33370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.
    Meltzer LT; Caprathe BW; Christoffersen CL; Corbin AE; Jaen JC; Ninteman FW; Pugsley TA; Serpa KA; Shih YH; Whetzel SZ
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1177-89. PubMed ID: 8103791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Change in dopamine and serotonin receptor sensitivity following chronic chlorpromazine administration].
    Zharkovskiĭ AM; Riago LK; Arro AG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1980; 30(1):165-8. PubMed ID: 7189932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-inhibitory dopamine-receptors and central effects of apomorphine.
    Di Chiara G; Porceddu ML; Morelli M; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):111-22. PubMed ID: 756166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of apomorphine and dopamine on the arterial blood pressure in anesthetized rat.
    Grabowska M
    Pol J Pharmacol Pharm; 1974; 26(3):305-15. PubMed ID: 4854743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.